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Purpose: This study was conducted to investigate the effect of flavonoids, a major family of antioxidants contained in
foods, on retinal ganglion cell (RGC) death induced by hypoxia, excessive glutamate levels, and oxidative stress.
Moreover, to assess the structure-activity relationships of flavonoids, three types of flavonoids with different numbers of
hydroxyl groups and varieties of sugar chains were studied.
Methods: Three kinds of flavonoids—nicotiflorin, rutin, and quercitrin—were used. The death of neonatal rat purified
RGCs was induced by hypoxic conditions (5% O2, 5% CO2, 37 °C) for 12 h, 25 µM glutamate over three days, or oxidative
stress by depleting antioxidants from the medium for 24 h. RGC survival rates were calculated under each condition and
compared with vehicle cultures. Modification of cell death signaling after stress-induced apoptosis and necrosis by
flavonoids was assessed using caspase-3 and calpain immunoreactivity assays.
Results: Under hypoxic and glutamate stress, both nicotiflorin and rutin significantly increased the RGC survival rate at
1 nM or higher, while quercitrin increased it at 100 nM or higher. Under oxidative stress, nicotiflorin, rutin, and quercitrin
also significantly increased the RGC survival rate at 1 nM, 0.1 nM, and 100 nM or higher, respectively. Rutin significantly
inhibited the induction of caspase-3 under both hypoxia and excessive glutamate stress, as well as blocking the induction
of calpain during oxidative stress.
Conclusions: Nicotiflorin and rutin showed neuroprotective effects on hypoxia-, glutamate- or oxidative stress–induced
RGC death at concentrations of 1 nM or higher. The presence of a specific sugar side chain (rutinoside) may enhance
neuroprotective activity.
Hypoxia, glutamate, and oxidative stress are important
factors in ocular disease states affecting retinal ganglion cells
(RGCs). Retinal ischemic and inflammatory diseases such as
retinal  vascular  occlusion  or  diabetic  retinopathy  elicit
hypoxic and/or oxidative stress–induced RGC death [1-3].
Likewise, RGC death in glaucoma is believed to be induced
by  apoptotic  mechanisms  triggered  by  multiple  stimuli,
including  ischemia,  oxidative  stress,  and  elevation  of
glutamate levels [4,5]. Numerous studies have demonstrated
that excessive glutamate induces RGC death in vitro and in
vivo [6], and that the glutamate receptor antagonists a non-
competitive antagonist of the N-methyl-d-aspartate (NMDA)
receptor, (MK801) or memantine can ameliorate RGC death
caused  by  elevated  intraocular  pressure  [7-11].  Oxidative
stress induced either by increased levels of reactive oxygen
species (ROS) or mitochondrial dysfunction is also implicated
in glaucomatous, ischemic, and hereditary optic neuropathies
[12,13].
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Flavonoids  comprise  a  large  family  of  plant-derived
compounds widely distributed in fruits and vegetables [14,
15]. There is growing evidence from human nutrition studies
that the absorption and bioavailability of specific flavonoids
is much higher than originally believed [15,16]. Flavonoids
are believed to exert protective as well as beneficial effects on
multiple  disease  states,  including  cancer,  cardiovascular
disease, and neurodegenerative disorders [15,17,18]. These
physiologic benefits of flavonoids are generally thought to be
derived from their antioxidant and free radical–scavenging
properties  [19].  Accordingly,  flavonoids  may  also  have
therapeutic potential in ocular diseases. However, only four
studies describing the potential effects of flavonoids on RGC
death using RGC-5 transgenic cell lines or in vivo rodent
models have been reported [20-23].
In the current study, we selected three types of flavonoid
compounds—kaempferol  3-O-rutinoside  (nicotiflorin),
quercetin  3-O-rutinoside  (rutin),  and  quercetin  3-O-
rhamnoside  (quercitrin)—from  more  than  7,000  known
flavonoids, and investigated their neuroprotective potential
using rat primary-isolated RGCs cultured under three kinds of
stress conditions: hypoxia, excessive glutamate levels, and
oxidative  stress.  Since  these  three  compounds  have  quite
similar structures, excluding the number of hydroxyl groups
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1784and sugar side chains, the structure-activity relationships for
neuroprotective activity were also considered.
METHODS
Animals: Six- to eight-day-old Wistar rats were purchased
from  Saitama  Laboratory  Animal  Supply  Inc.  (Saitama,
Japan). All animal experiments were conducted with approval
from the Animal Care and Use Committee and under the
guidelines of the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research.
Materials: Cell culture reagents were obtained from Gibco
(Grand  Island,  NY).  A  cell-dissection  kit  of  papain  was
obtained  from  Worthington  Biochemical  (Lakewood,  NJ).
Calcein-AM was obtained from Sigma (St. Louis, MO). Poly-
L-lysine, BSA, L-glutamine, and recombinant neurotrophic
factors  (human  brain-derived  neurotrophic  factor  and  rat
ciliary  neurotrophic  factor)  were  obtained  from  Sigma.
Monoclonal antibodies (OX-41) against rat macrophages and
monoclonal antibodies (OX-7) against rat and mouse Thy-1.1
were  obtained  from  Chemicon  (Temecula,  CA).  B-27
supplement  minus  antioxidants  (AO-)  was  obtained  from
Gibco.  The  origins  of  the  flavonoids  were  as  follows:
kaempferol 3-O- rutinoside (nicotiflorin) was purchased from
Extrasynthese  (Genay,  France);  quercetin  3-O-rhamnoside
(quercitrin)  was  from  Synthese  (Lab  Sarget,  Merignac,
France); and quercetin 3- O-rutinoside (rutin) was purified by
one of the authors, Tsukasa Iwashina, from the flowers of
Astrophytum ornatum (Britton & Rose) [24]. All flavonoids
were dissolved in 100% ethanol and diluted into a 10 mM
solution with sterilized distilled water. The 10 mM flavonoid
stocks were filtered using 0.45 mm filters (DISMIC, Toyo
Roshi, Tokyo, Japan) for sterilization and stored at 4 °C in a
5 ml sterile tube (Greiner Bio-One, Frickenhausen, Germany)
until use. For the vehicle solutions, the same dilution process
was used. The chemical structures of these three compounds
are indicated. Unless noted, all other reagents were obtained
from Invitrogen (Carlsbad, CA).
Purification and culture of rat retinal ganglion cells: RGCs
were purified by a two-step immunopanning procedure, as
described previously [25]. Briefly, the dissociated retinal cells
from eight-day-old Wister rats were incubated in flasks (Nunc
A/S, Roskilde, Denmark), coated with an antirat macrophage
monoclonal antibody (1:50) to exclude macrophages, and then
incubated  in  tubes  (Corning,  Acton,  MA)  coated  with  an
antirat Thy1.1 monoclonal antibody (1:300). RGCs adherent
to the tubes were collected by centrifugation at 60× g for 5
min and seeded on 13 mm glass coverslips in a 24-well plate
that had been coated with 50 µg/ml poly-L-lysine (Sigma) and
1 µg/ml laminin (Invitrogen). Purified RGCs were plated at a
density of approximately 1,000 cells per well. RGCs were
cultured  in  serum-free  B27  complete  medium  containing
neurobasal  medium  (Invitrogen)  with  1  mM  L-glutamine
(Sigma),  B27  supplement  (Invitrogen),  40  ng/ml  human
recombinant brain-derived neurotrophic factor, 40 ng/ml rat
recombinant  ciliary  neurotrophic  factor,  10  µM  forskolin
(Sigma), 100 U/ml penicillin, and 100 µg/ml streptomycin.
Plates were incubated in a tissue culture incubator with a
humidified atmosphere containing 5% CO2 and 95% air at
37 °C for 3 days.
Induction of hypoxia, glutamate, and oxidative stress: After
culturing  for  three  days,  RGC  death  was  induced  by  the
following  three  conditions.  For  hypoxia,  the  plates  were
transferred  to  a  controlled-atmosphere  incubator  and
incubated for 12 h, during which oxygen levels were reduced
(hypoxic condition: 5% CO2, 90% N2, and 5% O2 mixture)
[26]. For excessive glutamate stress, 25 µM glutamate was
added to the serum-free B27 neurobasal medium containing
RGCs at a final concentration, and incubated for another three
days under normoxic conditions (5% CO2, 95% air, at 37 °C)
[27]. For oxidative stress, glass coverslips adhered with RGCs
were  moved  to  neurobasal  medium  containing  B27  with
diminished  antioxidants  (AO−)  including  reduced
glutathione,  vitamin  E,  vitamin  E  acetate,  catalase,  and
superoxide  dismutase  (B27  supplement  minus  AO  50×;
Invitrogen), and incubated for 24 h under normoxic conditions
[28].
Evaluation of the protective effects of flavonoids: Nicotiflorin
and rutin were added at final concentrations of 0.1 nM, 1 nM,
and 10 nM, and quercitrin at 10 nM, 100 nM, and 1 µM.
Culture  medium  with  flavonoids  were  made  by  a  serial
dilution with B27 neurobasal medium. In the present study, a
surviving RGC was defined as a cell with a calcein-AM-
stained cell body and a process extending at least three cell
diameters from the cell body [25,26,29]. All surviving RGCs
on each glass coverslip were counted at 200× magnification
using an inverted fluorescence microscope (Nikon Eclipse
TE300). In each experiment, the number of RGCs cultured in
nonstress conditions (control group) was set at 100%. In the
control culture, about 1,000 cells were counted in one assay.
We repeated at least eight assays for each experiment. The
percentage of surviving RGCs after stress was calculated and
normalized to the control group without stress and flavonoid
treatment. Each percentage is expressed in the text and figures
as the mean±standard deviation (SD).
Assessment of caspase-3 and calpain activity: In our previous
studies,  we  determined  the  cell  death  patterns  of  purified
RGCs where death was induced by hypoxia, glutamate, and
oxidative stress under our culture conditions, and found that
both hypoxia- and glutamate-induced death mainly involved
mitochondrial-dependent and Bax-mediated apoptosis [27],
while  oxidative  stress  mainly  induced  necrotic  cell  death
[28]. To investigate the effect of flavonoids on apoptotic and
necrotic cell death signaling, we measured the activity of
caspase-3, one of the main proteases related to apoptosis,
under stress in the presence or absence of 10 nM rutin. To
investigate the effect of flavonoids on necrotic cell death
signaling, we measured the activity of calpain, one of the main
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absence of 10 nM rutin. Caspase-3 activity was determined
by a Caspase-3/cpp32 Colorimetric Assay Kit (Bio Vision,
Mountain View, CA). Calpain activity was determined by a
Calpain Activity Assay Kit (Bio Vision, Mountain View, CA).
Both activities were determined by measures of absorbance at
the 405 nm wavelength.
Statistical analyses: The Student t test or one-way ANOVA
followed by Dunnett’s test were used in this study. All data
are indicated as mean±SD.
RESULTS
Effect of flavonoids on hypoxia-induced retinal ganglion cell
death: After 12 h of hypoxia stress, the RGC survival rate
without nicotiflorin was reduced to 56.0±3.1%. The RGC
survival  rates  of  the  nicotiflorin-treated  group  were
54.3±3.2%,  62.3±1.9%,  73.8±2.0%,  71.4±4.9%,  and
56.1±3.2% at final concentrations of 0.1 nM, 1 nM, 10 nM,
100  nM,  and  1  µM,  respectively  (Figure  1A).  The  RGC
survival rate without rutin was reduced to 56.0±3.1%. The
RGC survival rates of the rutin-treated group were 58.4±3.5%,
64.3±2.8%, 76.7±3.2%, 75.0±3.9%, and 58.4±1.6% at final
concentrations of 0.1 nM, 1 nM, 10 nM, 100 nM, and 1 µM,
respectively  (Figure  1B).  The  RGC  survival  rate  without
quercitrin was reduced to 55.5±10.0%. The RGC survival
rates  of  the  quercitrin-treated  group  were  56.9±8.9%,
72.0±13.4%, 76.0±9.9%, 56.4±2.7%, and 54.6±3.0% at final
concentrations of 10 nM, 100 nM, 1 µM, 10 µM, and 100 µM,
respectively (Figure 1C). The addition of nicotiflorin and rutin
at 1 nM, 10 nM, and 100 nM, and quercitrin at 100 nM and
1 µM, significantly increased RGC viability (p<0.05 versus
vehicle by Dunnett’s test, n=8; Figure 1).
Effect of flavonoids on glutamate-induced retinal ganglion
cell death: After 72 h of glutamate stress, the RGC survival
rate without nicotiflorin was reduced to 69.8±7.4%. The RGC
survival  rates  in  the  nicotiflorin-treated  group  were
71.4±9.2%,  80.9±7.8%,  89.1±5.2%,  85.7±3.4%,  and
72.2±2.6% at final concentrations of 0.1 nM, 1 nM, 10 nM,
100  nM,  and  1  µM,  respectively  (Figure  2A).  The  RGC
survival rate without rutin was reduced to 69.8±7.4%. The
RGC survival rates of the rutin-treated group were 68.5±9.6%,
79.5±9.5%, 87.6±9.9%, 85.8±4.1%, and 69.5±2.9% at final
concentrations of 0.1 nM, 1 nM, 10 nM, 100 nM, and 1 µM,
respectively  (Figure  2B).  The  RGC  survival  rate  without
Figure 1. Effects of nicotiflorin (A), rutin (B), and quercitrin (C) against hypoxia-induced retinal ganglion cell death. Each bar represents
mean±standard deviation (SD; n=8). The asterisks indicate p<0.05 versus hypoxia vehicle (black bar) by Dunnett’s tests.
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1786quercitrin was reduced to 61.8±5.4%. The RGC survival rates
of the quercitrin-treated group were 58.2±8.0%, 73.0±9.8%,
80.0±5.5%,  63.2±3.3%,  and  59.9±1.8%  at  final
concentrations of 10 nM, 100 nM, 1 µM, 10 µM, and 100 µM,
respectively (Figure 2C). The addition of nicotiflorin and rutin
at 1 nM, 10 nM, and 100 nM, and quercitrin at 100 nM and
1 µM, significantly increased RGC viability (p<0.05 versus
vehicle by Dunnett’s test, n=8; Figure 2).
Effect  of  flavonoids  on  oxidative  stress–induced  retinal
ganglion cell death: After 24 h of oxidative stress, the RGC
survival rate without nicotiflorin was reduced to 44.4±8.1%.
The RGC survival rates of the nicotiflorin-treated group were
45.4±12.6%,  57.3±15.8%,  71.2±9.9%,  70.8±4.1%,  and
48.1±2.9% at final concentrations of 0.1 nM, 1 nM, 10 nM,
100  nM,  and  1  µM,  respectively  (Figure  3A).  The  RGC
survival rate without rutin was reduced to 44.4±8.1%. The
RGC survival rates of the rutin-treated group were 39.9±3.4%,
66.6±11.2%,  66.7±14.5%,  74.2±10%,  66.4±2.3%,  and
44.0±4.2% at final concentrations of 0.01 nM, 0.1 nM, 1.0
nM, 10 nM, 100 nM, and 1 µM, respectively (Figure 3B). The
RGC  survival  rate  without  quercitrin  was  reduced  to
57.7±8.7%. The RGC survival rates of the quercitrin-treated
group  were  67.4±14.7%,  80.0±9.1%,  76.5±10.8%,
63.1±1.9%, and 61.9±3.2% at final concentrations of 10 nM,
100 nM, 1 µM, 10 µM, and 100 µM, respectively (Figure 3C).
The addition of nicotiflorin at 1 nM, 10 nM, and 100 nM; rutin
at 0.1 nM, 1 nM, 10 nM, and 100 nM; and quercitrin at 100
nM and 1 µM significantly increased RGC viability (p<0.05
versus vehicle by Dunnett’s test, n=8; Figure 3).
Caspase-3  activity  in  stress-induced  retinal  ganglion  cell
death: After 12 h of hypoxia, caspase-3 activity in RGCs
without  rutin  was  0.80±0.14,  whereas  caspase-3  activity
without hypoxia was 0.55±0.11. Caspase-3 activities with
rutin  were  0.62±0.1,  0.58±0.21,  and  0.59±0.09  at  final
concentrations of 1 nM, 10 nM, and 100 nM, respectively
(arbitrary  units).  Rutin  showed  a  significant  reduction  of
caspase-3 activity under hypoxia (p<0.05 by Dunnett’s test
compared to hypoxia stress only, n=6; Figure 4A).
After 72 h of glutamate stress, caspase-3 activity in RGCs
without  rutin  was  0.84±0.25,  whereas  caspase-3  activity
without  glutamate  was  0.54±0.14.  Caspase-3  activities  in
RGCs with rutin were 0.63±0.13, 0.61±0.15, and 0.62±0.09
at  final  concentrations  of  1  nM,  10  nM,  and  100  nM,
Figure 2. Effects of nicotiflorin (A), rutin (B), and quercitrin (C) against 25 µM glutamate-induced retinal ganglion cell death. Each bar
represents mean±standard deviation (SD; n=8). The asterisks indicate p<0.05 versus glutamate vehicle (black bar) by Dunnett’s tests.
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1787respectively  (arbitrary  units).  Rutin  showed  a  significant
reduction of caspase-3 activity by glutamate stress (p<0.05 by
Dunnett’s test compared to glutamate stress only, n=6; Figure
4B).
After 24 h of oxidative stress, caspase-3 activity in RGCs
without  rutin  was  0.61±0.02,  whereas  caspase-3  activity
without oxidative stress was 0.51±0.03. Caspase-3 activities
in RGCs with rutin were 0.58±0.02, 0.59±0.02, and 0.59±0.04
at  final  concentrations  of  1  nM,  10  nM,  and  100  nM,
respectively (arbitrary units). There was no significant change
of caspase-3 activity by oxidative stress (n=6; Figure 4C).
Calpain activity in oxidative stress–induced retinal ganglion
cell death: After 12 h of hypoxia, calpain activity in RGCs
without  rutin  was  0.59±0.03,  whereas  caspase-3  activity
without hypoxia was 0.51±0.03. Calpain activities in RGCs
with rutin were 0.60±0.4, 0.58±0.02, and 0.58±0.05 at final
concentrations of 1 nM, 10 nM, and 100 nM, respectively
(arbitrary units). There was no significant change of calpain
activity under hypoxia (n=6; Figure 5A).
After 72 h of glutamate stress, calpain activity in RGCs
without  rutin  was  0.60±0.03,  whereas  caspase-3  activity
without glutamate was 0.51±0.03. Calpain activities in RGCs
with rutin were 0.62±0.02, 0.58±0.04, and 0.59±0.03 at final
concentrations of 1 nM, 10 nM, and 100 nM, respectively
(arbitrary units). There was no significant change of calpain
activity under hypoxia (n=6; Figure 5B).
After 24 h of oxidative stress, calpain activity in RGCs
without  rutin  was  0.78±0.19,  whereas  caspase-3  activity
without oxidative stress was 0.56±0.14. Calpain activities in
RGCs with rutin were 0.59±0.13, 0.58±0.23, 0.57±0.13 at
final concentrations of 1 nM, 10 nM, and 100 nM, respectively
(arbitrary  units).  Rutin  showed  significant  reduction  of
calpain activity by oxidative stress (p<0.05 by Dunnett’s test
compared to oxidative stress only, n=6; Figure 5C).
DISCUSSION
Our  results  using  rat  purified  primary  RGC  cultures  first
indicated that flavonoids had a strong neuroprotective effect
against RGC death induced by hypoxia, excessive glutamate
levels, and oxidative stress. Experiments using rutin indicated
that flavonoids could influence both apoptotic and necrotic
RGC death at concentrations as low as 1 nM. Moreover, the
structure-activity relationships among the three flavonoids
indicated that the rutinoside sugar chain might be important
in exerting neuroprotective activity.
Figure 3. Effects of nicotiflorin (A), rutin (B), and quercitrin (C) against oxidative stress–induced retinal ganglion cell death. Each bar
represents mean±SD (n=8). The asterisks indicate p<0.05 versus oxidative stress vehicle (black bar) by Dunnett’s tests.
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1788In this study, we only selected three kinds of flavonols,
which had similar chemical structures. Although many other
number of flavonoids should be assessed to identify more
details  of  the  structure-activity  relationships  for  various
stresses, there was a limitation in obtaining the necessary
number of purified rat RGCs for our biologic assays. The
RGC-5 cell line is useful for a large amount of cells, but the
nature of the cells is quite different for the primary RGCs
[30]. A more easy and efficient assay system to screen and
select the effective drugs should be developed in future.
Effectiveness at a low dose: In the current study, a rat
purified RGC culture system was used as an experimental
model to survey the neuroprotective effects of flavonoids on
RGC death induced by three kinds of stresses. The effective
doses  of  two  flavonoids  were  very  low  (~1  nM).  In  our
previous studies using the same hypoxic culture system, the
effective doses of lomerizine, a Ca2+ channel blocker, and
betaxolol,  an  antiglaucoma  drug  with  weak  Ca2+  channel
blocking activity, were 10 and 100 nM, respectively [26,27].
Thus,  flavonoids  may  be  more  effective  neuroprotective
agents than Ca2+ channel blockers, which are well known
neuroprotectants for ischemia-induced cell death [31].
In previous reports about flavonoids using the RGC-5 cell
line, the effective doses (over 10 µM) were quite a bit higher
than our results, although the examined flavonoids and the
conditions to induce RGC-5 cell death were different from
those used in our experiments [20-23]. Another reason for this
discrepancy could be the use of an immortalized RGC-5 cell
line that may be more tolerant than primarily isolated RGCs
against  various  stresses.  Additionally,  a  recent  report
indicated that RGC-5 had different characteristics from the
original  cells  in  terms  of  missing  RGC  cell  markers  and
conventionally expressed proteins [30]. Two previous reports
using in vivo rodent models indicated that intraperitoneal
injection of the flavonoid baicalin (15 mg/kg) or catechin
(25  mg/kg)  was  neuroprotective,  but  the  actual  tissue
concentrations of these substances were not measured [20,
23]. Based on the current results, rutin and nicotiflorin may
deserve further study to validate their in vivo neuroprotective
potential.
Figure 4. Effect of rutin on caspase-3 activity induced by hypoxia (A), glutamate (B), and oxidative stress (C). The asterisks indicate p<0.05
by Dunnett’s tests compared to stress only (black bar).
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1789Structure-activity  relationships  conferring
neuroprotection: So far, there have been no reports comparing
flavonoid  structure-activity  relationships.  This  is  the  first
study to indicate the differences in biologic activities among
three kinds of flavonoids with a similar chemical structure
(shown  in  Figure  6).  Although  the  precise  mechanism  of
action remains unclear, the beneficial activity of flavonoids is
generally attributed to their antioxidative efficacy [19,32,33].
The  antioxidant  capacity  of  flavonoids  depends  on  the
arrangement of functional groups surrounding the flavonol
nucleus, which may directly affect glutathione metabolism,
antioxidant capacity, or the ability to maintain low Ca2+ levels
despite  high  levels  of  ROS  [14,19].  In  this  study,  both
nicotiflorin  and  rutin  displayed  neuroprotective  effects  at
concentrations of 1 nM or higher, whereas quercitrin was only
effective at 100 nM or higher. Comparison of the chemical
structures of the three flavonoids (Figure 6) indicates that the
sugar  side  chain  may  be  important  for  neuroprotective
activity, since quercitrin (with the same quercetin nucleus as
rutin, but with a rhamnoside sugar chain in lieu of a rutinoside
sugar  chain)  showed  about  100  times  weaker  efficacy
compared to rutin. In comparison, the numbers of hydroxyl
groups  in  the  flavonol  nucleus  may  be  unrelated  to  the
antioxidative activity, because nicotiflorin and rutin showed
similar neuroprotective activity despite possessing a different
number of hydroxyl groups (Figure 6). This novel finding
regarding flavonoid structure-activity relationships may be
useful  in  the  development  of  more  effective  flavonoid
antioxidants.
Unknown mechanism of action: Oxidative stress has been
implicated in many types of ocular diseases. Several previous
reports have shown that RGC damage under oxidative stress
is mainly linked with increased intracellular ROS and calcium
influx [22,28]. During ischemia/reperfusion in ocular vascular
diseases, tissue reoxygenation also induced an overproduction
of  ROS  [1-3].  Furthermore,  some  studies  indicated  that
excitatory transmitter amino acids such as glutamate were
released  under  oxidative  and  hypoxic  stresses  [27,34-36].
Therefore, one of the reasons that flavonoids were effective
not only for oxidative stress but also for hypoxic or excessive
glutamate stress might be due to a partial involvement of
oxidative stress factors in hypoxia- or glutamate-induced cell
Figure 5. Effect of rutin on calpain activity induced by hypoxia (A), glutamate (B), and oxidative stress (C). The asterisks indicate p<0.05 by
Dunnett’s tests compared to stress only (black bar).
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1790death. On the other hand, it is also possible that flavonoids
have  effects  other  than  antioxidation  during  hypoxia-  or
glutamate-induced cell death.
Rutin, as a representative of the three flavonoids, caused
a  significant  inhibition  of  both  apoptotic  and  necrotic
pathways in RGCs. In this study, we investigated the effect of
rutin on the activities of caspase-3 and calpain, which are the
representative proteases in apoptotic and necrotic pathways,
respectively. As a result, rutin suppressed these activities, but
there was no dose-dependency. These data suggest that other
protective signals in addition to caspase-3 or calpain may be
present. There is a limitation to investigating the signaling
molecules related to apoptosis and necrosis using primary
cultures of RGCs, because a large number of primary cells is
required  for  biochemical  assays  targeting  various  death
signals.  Further  experiments  are  required  to  clarify  the
mechanism of these flavonols.
Clinical relevance of flavonoids: Nicotiflorin and rutin,
with  only  one  hydroxyl  group  difference  between  them
structurally, are contained mainly in fruits and vegetables.
Quercitrin, with a different sugar side chain than rutin, is
contained  mainly  in  tea  and  some  medicinal  plants.  The
beneficial effects of dietary plant substances containing these
flavonoids has been recorded since ancient times and passed
on for generations. Buckwheat and tartary buckwheat, which
are commonly ingested in Japan and other Asian countries,
are both rich in rutin; amazingly, rutin accounts for as high as
1% of the total weight of buckwheat and tartary buckwheat
[37,38]. A few reports have indicated that repeated intake of
several  hundred  milligrams  of  rutin  resulted  in  a  plasma
concentration of 100 nM or higher [39-41]. Moreover, it has
been reported that flavonoids can penetrate into the central
nervous  system  through  the  blood-brain  barrier  [42].
Currently, their multitudinous pharmacological effects, such
as their antioxidant capacity and anticancer effects, are being
scientifically and clinically evaluated in the hopes of reducing
the  risk  of  cardiovascular  disease  and/or  inhibiting  tumor
angiogenesis [17,37,43-48]. Our current results also suggest
that flavonoids have the potential to be clinically useful for
hypoxia-,  glutamate-,  or  oxidative  stress–related  RGC
morbidities.
Figure 6. Structures and effective concentrations of nicotiflorin, rutin, and quercitrin against the three stresses. Note the difference in side
chains enclosed by rectangles. P-value<0.05 by calculated in Dunnett's tests compared to stress only. The result showed that neuroprotective
concentration of quercitrin is different with nicotiflorin and rutin. It is shown that different structures of changing side chain induced different
concentrations of neuroprotection.
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1791Conclusion: In summary, we studied the neuroprotective
effects of three kinds of flavonoids using purified rat RGC
cultures, and found that nicotiflorin and rutin had beneficial
effects  on  hypoxic,  glutamate,  and  oxidative  stress  at
concentrations  as  low  as  1  nM.  The  structure-activity
relationships suggested that the sugar side chain of flavonoids
might be important for neuroprotective activities. Moreover,
rutin showed inhibitory effects on both apoptotic and necrotic
pathways.  Nicotiflorin  and  rutin  have  the  potential  to  be
promising neuroprotective drugs in the future.
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